sorafenib has been researched along with rhodamine 123 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, MR; Li, AM; Lü, CW; Luo, RC; Su, N; Wei, L; Yan, X; Zheng, DY | 1 |
1 other study(ies) available for sorafenib and rhodamine 123
| Article | Year |
|---|---|
[Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Exocytosis; Flow Cytometry; Humans; Immunohistochemistry; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Sorafenib | 2009 |